Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Journal of Neurology
- Volume
- 273
- Issue
- 4
- Publication date
- 25 March 2026
- Language
- EN